51 – 60 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
Steuber, Thomas ; Vickers, Andrew ; Haese, Alexander ; Kattan, Michael W. ; Eastham, James A. ; Scardino, Peter T. ; Huland, Hartwig and Lilja, Hans LU
(2007)
In International Journal of Cancer
120(7).
p.1499-1504
- Contribution to journal › Article
- 2006
-
Mark
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
Bjartell, Anders LU ; Johansson, Rebecka ; Björk, Thomas LU ; Gadaleanu, Virgil ; Lundwall, Åke LU ; Lilja, Hans LU
; Kjeldsen, Lars
and Udby, Lene
(2006)
In The Prostate
66(Dec 30).
p.591-603
- Contribution to journal › Article
-
Mark
Truncated semenogelin I binds zinc and is cleaved by prostate-specific antigen
Jonsson, Magnus LU
; Lundwall, Åke
LU
; Linse, Sara
LU
; Frohm, Birgitta
LU
and Malm, Johan
LU
(2006)
In Journal of Andrology
27(4).
p.542-547
- Contribution to journal › Article
-
Mark
Biochemical Studies of Semenogelins with Emphasis on Zinc-Binding Properties
Jonsson, Magnus LU
(2006)
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
Ceder, Yvonne LU
; Bjartell, Anders
LU
; Lilja, Hans
LU
and Lundwall, Åke
LU
(2005)
In International Journal of Cancer
113(2).
p.290-297
- Contribution to journal › Article
-
Mark
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
Haese, A ; Vaisanen, V ; Lilja, Hans LU
; Kattan, M W
; Rittenhouse, H G
; Pettersson, K
; Chan, D W
; Huland, H
; Sokoll, L J
and Partin, A W
(2005)
In Journal of Urology
173(3).
p.752-756
- Contribution to journal › Article
- 2004
-
Mark
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
Hugosson, J ; Aus, G ; Lilja, Hans LU
; Lodding, P
and Pihl, CG
(2004)
In Cancer
100(7).
p.1397-1405
- Contribution to journal › Article
-
Mark
Lead time associated with screening for prostate cancer
Tornblom, M ; Eriksson, H ; Franzen, S ; Gustafsson, O ; Lilja, Hans LU
; Norming, U
and Hugosson, J
(2004)
In International Journal of Cancer
108(1).
p.122-129
- Contribution to journal › Article
-
Mark
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
Zackrisson, B ; Aus, G ; Bergdahl, S ; Lilja, Hans LU
; Lodding, P
; Pihl, CG
and Hugosson, J
(2004)
In Journal of Urology
171(4).
p.1500-1503
- Contribution to journal › Article
-
Mark
Structure, evolution and expression of glandular kallikrein genes
Ceder, Yvonne LU
(2004)
- Thesis › Doctoral thesis (compilation)